Munir, T., Brown, J. R., O'Brien, S., Barrientos, J. C., Barr, P. M., Reddy, N. M., . . . Woyach, J. A. (2019). Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma. Am J Hematol.
Citación estilo ChicagoMunir, Talha, et al. "Final Analysis From RESONATE: Up to Six Years of Follow‐up On Ibrutinib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Am J Hematol 2019.
Cita MLAMunir, Talha, et al. "Final Analysis From RESONATE: Up to Six Years of Follow‐up On Ibrutinib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Am J Hematol 2019.